SANTEN PHARMACEUTICAL CO., LTD.
参天製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4536
FY2025 · 2026-03-31
| Gross margin | 58.2% |
| Operating margin | 16.4% |
| Net margin | 12.8% |
| Return on equity | 12.6% |
| Return on assets | 8.8% |
| Revenue growth (YoY) | -2.8% |
| EPS (basic) | ¥114.04 |
| EPS growth (YoY) | 9.7% |
| Current ratio | — |
| Equity ratio | 70.2% |
| Book value / share | ¥394.39 |
| Free cash flow | 36,656 M |